comparemela.com
Home
Live Updates
Lifesci Venture Partners - Breaking News
Pages:
6
7
8
9
10
11
12
Latest Breaking News On - Lifesci venture partners - Page 5 : comparemela.com
Orasis Pharmaceuticals to Present New Data on Novel Presbyopia Candidate at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
/PRNewswire/ Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to improve near vision for people.
United states
Tel aviv
Amy phillips
Marjan farid
Preeyak gupta
Elad kedar
American society for cataract
Japan innovation fund
Sequoia capital
Orasis pharmaceuticals
Prnewswire orasis pharmaceuticals
Refractive surgery
Annual meeting
Chief executive officer
Orasis pharmaceutical
New treatments
Orasis Pharmaceuticals Appoints Teresa (Tes) Ignacio, M D as Vice President, Medical Affairs
HERZLIYA, Israel, April 7, 2022 /PRNewswire/ Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a uniq.
Tel aviv
Amy phillips
Paul smith
Refractive research
Makati medical center
Japan innovation fund
Orasis pharmaceuticals
Prnewswire orasis pharmaceuticals
Prnewsfoto orasis pharmaceuticals
Sequoia capital
Vice president
Chief operating officer
Refractive research fellow
About orasis
Visionary ventures
Innovation fund
Orasis Pharmaceuticals Concludes Phase 3 Clinical Trials for Presbyopia Candidate
Study enrollment complete for NEAR-1 and NEAR-2 Phase 3 Clinical TrialsHERZLIYA, Israel, March 15, 2022 /PRNewswire/ Orasis Pharmaceuticals, an.
Tel aviv
Amy phillips
Elad kedar
Japan innovation fund
Sequoia capital
Orasis pharmaceuticals
Prnewswire orasis pharmaceuticals
Chief executive officer
Visionary ventures
Innovation fund
Bluestem capital
Lifesci venture partners
Maverick ventures israel
Orasis Pharmaceuticals Concludes Phase 3 Clinical Trials for Presbyopia Candidate
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Tel aviv
Amy phillips
Elad kedar
Japan innovation fund
Sequoia capital
Orasis pharmaceuticals
Prnewswire orasis pharmaceuticals
Chief executive officer
Visionary ventures
Innovation fund
Bluestem capital
Lifesci venture partners
Maverick ventures israel
Pr newswire
Clinical trials
Clade Therapeutics Announces the Appointment of Derek Hei, Ph D , as Chief Technology Officer
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
United states
United kingdom
Ligia vela reid
Waisman biomanufacturing
Bristol myers squibb
University of wisconsin
Regulatory at cellular dynamics international
University of california
Gene therapies at vertex pharmaceuticals
Derek hei
Chief technology officer
Chad cowan
Chief executive officer
Senior vice president
Clinical manufacturing
Gene therapies
vimarsana © 2020. All Rights Reserved.